CA2156718A1
(en)
*
|
1993-12-23 |
1995-06-29 |
Bruno Gander |
Immunological response potentiation process
|
DE69528074T2
(de)
*
|
1994-09-23 |
2003-04-30 |
Zonagen, Inc. |
Chitosan induzierte verstärkung
|
US6030613A
(en)
*
|
1995-01-17 |
2000-02-29 |
The Brigham And Women's Hospital, Inc. |
Receptor specific transepithelial transport of therapeutics
|
ATE331438T1
(de)
*
|
1995-01-17 |
2006-07-15 |
Brigham & Womens Hospital |
Rezeptorspezifischer transepithelealer transport von immunogenen
|
US6086875A
(en)
*
|
1995-01-17 |
2000-07-11 |
The Brigham And Women's Hospital, Inc. |
Receptor specific transepithelial transport of immunogens
|
US6485726B1
(en)
|
1995-01-17 |
2002-11-26 |
The Brigham And Women's Hospital, Inc. |
Receptor specific transepithelial transport of therapeutics
|
DE19511276C2
(de)
*
|
1995-03-27 |
1999-02-18 |
Immuno Ag |
Adjuvans auf der Basis kolloidaler Eisenverbindungen
|
US6592877B1
(en)
*
|
1995-09-01 |
2003-07-15 |
Corixa Corporation |
Compounds and methods for immunotherapy and diagnosis of tuberculosis
|
US6290969B1
(en)
*
|
1995-09-01 |
2001-09-18 |
Corixa Corporation |
Compounds and methods for immunotherapy and diagnosis of tuberculosis
|
US6458366B1
(en)
|
1995-09-01 |
2002-10-01 |
Corixa Corporation |
Compounds and methods for diagnosis of tuberculosis
|
US20050003431A1
(en)
*
|
1996-08-16 |
2005-01-06 |
Wucherpfennig Kai W. |
Monovalent, multivalent, and multimeric MHC binding domain fusion proteins and conjugates, and uses therefor
|
US6884435B1
(en)
|
1997-01-30 |
2005-04-26 |
Chiron Corporation |
Microparticles with adsorbent surfaces, methods of making same, and uses thereof
|
EP1275380A1
(en)
*
|
1997-01-30 |
2003-01-15 |
Chiron Corporation |
Use of microparticles with adsorbed antigen to stimulate immune responses
|
DK0991403T3
(da)
*
|
1997-01-30 |
2003-07-28 |
Chiron Corp |
Anvendelse af mikropartikler med adsorberet antigen til stimulering af immunresponser
|
US20060165606A1
(en)
*
|
1997-09-29 |
2006-07-27 |
Nektar Therapeutics |
Pulmonary delivery particles comprising water insoluble or crystalline active agents
|
US6254890B1
(en)
*
|
1997-12-12 |
2001-07-03 |
Massachusetts Institute Of Technology |
Sub-100nm biodegradable polymer spheres capable of transporting and releasing nucleic acids
|
US20020147143A1
(en)
|
1998-03-18 |
2002-10-10 |
Corixa Corporation |
Compositions and methods for the therapy and diagnosis of lung cancer
|
US20030235557A1
(en)
|
1998-09-30 |
2003-12-25 |
Corixa Corporation |
Compositions and methods for WT1 specific immunotherapy
|
US20040009535A1
(en)
|
1998-11-27 |
2004-01-15 |
Celltech R&D, Inc. |
Compositions and methods for increasing bone mineralization
|
US8143386B2
(en)
*
|
1999-04-07 |
2012-03-27 |
Corixa Corporation |
Fusion proteins of mycobacterium tuberculosis antigens and their uses
|
AU779978B2
(en)
*
|
1999-10-07 |
2005-02-24 |
Corixa Corporation |
Fusion proteins of mycobacterium tuberculosis
|
EP1221968B1
(en)
*
|
1999-10-13 |
2010-01-13 |
Novartis Vaccines and Diagnostics, Inc. |
Method of obtaining cellular immune responses from proteins
|
CZ303468B6
(cs)
|
2000-02-23 |
2012-10-03 |
Smithkline Beecham Biologicals S. A. |
Imunogenní smes a farmaceutická smes
|
AU2001241738A1
(en)
|
2000-02-25 |
2001-09-03 |
Corixa Corporation |
Compounds and methods for diagnosis and immunotherapy of tuberculosis
|
US20040002068A1
(en)
|
2000-03-01 |
2004-01-01 |
Corixa Corporation |
Compositions and methods for the detection, diagnosis and therapy of hematological malignancies
|
WO2001066700A1
(en)
*
|
2000-03-09 |
2001-09-13 |
Emory University |
Transcutaneous immunization for large particulate antigens
|
EP1278542A2
(en)
|
2000-05-05 |
2003-01-29 |
Cytos Biotechnology AG |
Molecular antigen arrays and vaccines
|
US7871598B1
(en)
|
2000-05-10 |
2011-01-18 |
Novartis Ag |
Stable metal ion-lipid powdered pharmaceutical compositions for drug delivery and methods of use
|
US8404217B2
(en)
|
2000-05-10 |
2013-03-26 |
Novartis Ag |
Formulation for pulmonary administration of antifungal agents, and associated methods of manufacture and use
|
US7442388B2
(en)
|
2000-05-10 |
2008-10-28 |
Weers Jeffry G |
Phospholipid-based powders for drug delivery
|
AU2001268678B2
(en)
*
|
2000-06-20 |
2006-11-16 |
Corixa Corporation |
Fusion proteins of mycobacterium tuberculosis
|
EP1319069B1
(en)
|
2000-06-28 |
2008-05-21 |
Corixa Corporation |
Compositions and methods for the therapy and diagnosis of lung cancer
|
WO2002009674A2
(en)
*
|
2000-07-28 |
2002-02-07 |
Inhale Therapeutic Systems, Inc. |
Methods and compositions to upregulate, redirect or limit immune responses to bioactive compounds
|
AUPR011700A0
(en)
*
|
2000-09-14 |
2000-10-05 |
Austin Research Institute, The |
Composition comprising immunogenic virus sized particles (VSP)
|
DE60118228T2
(de)
*
|
2000-09-28 |
2006-12-14 |
Chiron Corp. (N.D.Ges.D. Staates Delaware), Emeryville |
Mikropartikel zur verabreichung von heterologen nukleinsäure
|
WO2002026212A2
(en)
|
2000-09-28 |
2002-04-04 |
Chiron Corporation |
Microparticle compositions and methods for the manufacture thereof
|
US7264810B2
(en)
*
|
2001-01-19 |
2007-09-04 |
Cytos Biotechnology Ag |
Molecular antigen array
|
US7618939B2
(en)
*
|
2001-02-15 |
2009-11-17 |
The Board Of Trustees Of The University Of Illinois |
Compositions and methods to prevent cancer with cupredoxins
|
US7491394B2
(en)
|
2001-02-15 |
2009-02-17 |
The Board Of Trustees Of The University Of Illinois |
Cytotoxic factors for modulating cell death
|
US20040126900A1
(en)
*
|
2001-04-13 |
2004-07-01 |
Barry Stephen E |
High affinity peptide- containing nanoparticles
|
JP2005504513A
(ja)
|
2001-05-09 |
2005-02-17 |
コリクサ コーポレイション |
前立腺癌の治療及び診断のための組成物及び方法
|
WO2003005952A2
(en)
|
2001-07-10 |
2003-01-23 |
Corixa Corporation |
Compositions and methods for delivery of proteins and adjuvants encapsulated in microspheres
|
ES2405405T3
(es)
|
2001-12-17 |
2013-05-31 |
Corixa Corporation |
Composiciones y procedimientos para la terapia y el diagnóstico de enfermedad inflamatoria del intestino
|
US20030219459A1
(en)
*
|
2002-01-18 |
2003-11-27 |
Cytos Biotechnology Ag |
Prion protein carrier-conjugates
|
US7026465B2
(en)
*
|
2002-02-15 |
2006-04-11 |
Corixa Corporation |
Fusion proteins of Mycobacterium tuberculosis
|
JP2005519619A
(ja)
*
|
2002-03-13 |
2005-07-07 |
麒麟麦酒株式会社 |
インフルエンザm2タンパク質に対するヒトモノクローナル抗体および上記抗体を作製しかつ利用する方法
|
US20040170606A1
(en)
*
|
2002-06-07 |
2004-09-02 |
Palmer Kenneth E. |
Production of peptides in plants as viral coat protein fusions
|
WO2003103605A2
(en)
*
|
2002-06-07 |
2003-12-18 |
Large Scale Biology Corporation |
Flexible vaccine assembly and vaccine delivery platform
|
US20040005338A1
(en)
*
|
2002-06-20 |
2004-01-08 |
Cytos Biotechnology Ag |
Packaged virus-like particles for use as adjuvants: method of preparation and use
|
AU2003246690B2
(en)
|
2002-07-17 |
2010-03-11 |
Cytos Biotechnology Ag |
Molecular antigen arrays using a virus like particle derived from the AP205 coat protein
|
BR0312297A
(pt)
*
|
2002-07-18 |
2005-04-12 |
Cytos Biotechnology Ag |
Conjugados veìculos de hapteno e seu uso
|
KR101070078B1
(ko)
*
|
2002-07-19 |
2011-10-04 |
노파르티스 파르마 아게 |
아밀로이드 베타1-6 항원 어레이를 포함하는 백신 조성물
|
US7807187B2
(en)
*
|
2003-05-13 |
2010-10-05 |
The University Of Massachusetts |
Endogenous adjuvant molecules and uses thereof
|
ATE437633T2
(de)
|
2003-06-02 |
2009-08-15 |
Novartis Vaccines & Diagnostic |
Immunogene zusammensetzungen auf basis von biologisch abbaubaren mikroteilchen enthaltend ein diphtherie- und ein tetanustoxoid
|
EP1636270B1
(en)
|
2003-06-16 |
2016-07-20 |
UCB Pharma S.A. |
Antibodies specific for sclerostin and methods for increasing bone mineralization
|
CA2542332C
(en)
*
|
2003-10-16 |
2013-03-12 |
Stephen John Ralph |
Immunomodulating compositions and uses therefor
|
BRPI0507002A
(pt)
*
|
2004-01-20 |
2007-06-05 |
Cytos Biotechnology Ag |
conjugados veìculos de grelina
|
AU2005285513B2
(en)
|
2004-05-25 |
2011-02-24 |
Oregon Health And Science University |
SIV and HIV vaccination using RhCMV- and HCMV-based vaccine vectors
|
WO2006045796A2
(en)
*
|
2004-10-25 |
2006-05-04 |
Cytos Biotechnology Ag |
Gastric inhibitory polypeptide (gip) antigen arrays and uses thereof
|
US9492400B2
(en)
|
2004-11-04 |
2016-11-15 |
Massachusetts Institute Of Technology |
Coated controlled release polymer particles as efficient oral delivery vehicles for biopharmaceuticals
|
GB0424563D0
(en)
*
|
2004-11-05 |
2004-12-08 |
Novartis Ag |
Organic compounds
|
BRPI0609547A2
(pt)
|
2005-03-31 |
2011-10-18 |
Glaxosmithkline Biolog Sa |
composição, uso de uma composição, método para o tratamento ou prevenção de infecção por chlamydia, uso de uma ou mais proteìnas de chlamydia, de fragmentos imunogênicos das mesmas ou de polinucleotìdeos codificando os mesmos, método para o tratamento ou prevenção de infecção por chlamydia, e, método para a determinação prévia de infecção por chlamydia em um indivìduo
|
CN106390108B
(zh)
|
2005-04-29 |
2020-09-08 |
葛兰素史密丝克莱恩生物有限公司 |
用于预防或治疗结核分枝杆菌感染的新方法
|
US7951384B2
(en)
*
|
2005-08-05 |
2011-05-31 |
University Of Massachusetts |
Virus-like particles as vaccines for paramyxovirus
|
US9216212B2
(en)
|
2005-08-05 |
2015-12-22 |
University Of Massachusetts |
Virus-like particles as vaccines for paramyxovirus
|
WO2007070682A2
(en)
|
2005-12-15 |
2007-06-21 |
Massachusetts Institute Of Technology |
System for screening particles
|
CA2648099C
(en)
|
2006-03-31 |
2012-05-29 |
The Brigham And Women's Hospital, Inc |
System for targeted delivery of therapeutic agents
|
JP5524610B2
(ja)
|
2006-04-07 |
2014-06-18 |
ザ リサーチ ファウンデーション オブ ステイト ユニバーシティー オブ ニューヨーク |
トランスコバラミン受容体ポリペプチド、核酸およびその調節因子、ならびに細胞の増殖の調節ならびにガンおよびコバラミン欠損症の処置に使用する関連方法
|
US7702468B2
(en)
|
2006-05-03 |
2010-04-20 |
Population Diagnostics, Inc. |
Evaluating genetic disorders
|
US10522240B2
(en)
|
2006-05-03 |
2019-12-31 |
Population Bio, Inc. |
Evaluating genetic disorders
|
US8367113B2
(en)
|
2006-05-15 |
2013-02-05 |
Massachusetts Institute Of Technology |
Polymers for functional particles
|
WO2007150030A2
(en)
*
|
2006-06-23 |
2007-12-27 |
Massachusetts Institute Of Technology |
Microfluidic synthesis of organic nanoparticles
|
WO2008019142A2
(en)
*
|
2006-08-04 |
2008-02-14 |
Massachusetts Institute Of Technology |
Oligonucleotide systems for targeted intracellular delivery
|
US9217129B2
(en)
|
2007-02-09 |
2015-12-22 |
Massachusetts Institute Of Technology |
Oscillating cell culture bioreactor
|
JP5391387B2
(ja)
*
|
2007-03-09 |
2014-01-15 |
小川 一文 |
磁気感応性薬剤およびその製造方法
|
WO2008124632A1
(en)
*
|
2007-04-04 |
2008-10-16 |
Massachusetts Institute Of Technology |
Amphiphilic compound assisted nanoparticles for targeted delivery
|
US8932558B2
(en)
*
|
2007-10-05 |
2015-01-13 |
Plaxgen Inc |
Multi-subunit biological complexes for treatment of plaque-associated diseases
|
MX350501B
(es)
|
2007-10-12 |
2017-09-07 |
Massachusetts Inst Technology |
Nanotecnologia de vacuna.
|
AU2009302241B2
(en)
|
2008-10-08 |
2015-10-29 |
Xgene Pharmaceutical Inc. |
GABA conjugates and methods of use thereof
|
US8343497B2
(en)
*
|
2008-10-12 |
2013-01-01 |
The Brigham And Women's Hospital, Inc. |
Targeting of antigen presenting cells with immunonanotherapeutics
|
US8277812B2
(en)
|
2008-10-12 |
2012-10-02 |
Massachusetts Institute Of Technology |
Immunonanotherapeutics that provide IgG humoral response without T-cell antigen
|
US8591905B2
(en)
|
2008-10-12 |
2013-11-26 |
The Brigham And Women's Hospital, Inc. |
Nicotine immunonanotherapeutics
|
US8343498B2
(en)
|
2008-10-12 |
2013-01-01 |
Massachusetts Institute Of Technology |
Adjuvant incorporation in immunonanotherapeutics
|
EA028288B1
(ru)
|
2009-05-27 |
2017-10-31 |
Селекта Байосайенсиз, Инк. |
Наноносители, имеющие компоненты с различными скоростями высвобождения
|
US20110038852A1
(en)
*
|
2009-06-10 |
2011-02-17 |
3-V Biosciences, Inc. |
Antivirals that target transporters, carriers, and ion channels
|
CN107715118A
(zh)
*
|
2009-08-26 |
2018-02-23 |
西莱克塔生物科技公司 |
诱导t细胞辅助的组合物
|
JP2013505022A
(ja)
|
2009-09-16 |
2013-02-14 |
バクサート インコーポレーティッド |
H1n1感染を予防するための免疫戦略の方法
|
DK2501716T3
(da)
|
2009-11-19 |
2015-04-07 |
Solis Biodyne Oü |
Sammensætninger til forhøjelse af polypeptidstabilitet og -aktivitet og tilhørende fremgangsmåder
|
BR112012018669A2
(pt)
|
2010-01-27 |
2017-09-05 |
Glaxosmithkline Biologicals Sa |
Proteína rv3616c modificada, uso de uma proteína rv3616c modificada, polinucleotídeo, uso de um polinucleotídeo, composição farmacêutica, composição imunogênica, proteína de fusão, e, polipeptídeo.
|
KR20130108983A
(ko)
|
2010-05-26 |
2013-10-07 |
셀렉타 바이오사이언시즈, 인크. |
커플링되지 않은 애주번트를 갖는 나노담체 조성물
|
WO2012018387A2
(en)
|
2010-08-02 |
2012-02-09 |
Population Diagnotics, Inc. |
Compositions and methods for discovery of causative mutations in genetic disorders
|
WO2012061717A1
(en)
|
2010-11-05 |
2012-05-10 |
Selecta Biosciences, Inc. |
Modified nicotinic compounds and related methods
|
EA031193B1
(ru)
|
2011-03-08 |
2018-11-30 |
3-В Байосайенсиз, Инк. |
Гетероциклические модуляторы синтеза липидов
|
CA2834532A1
(en)
|
2011-04-29 |
2012-11-01 |
Selecta Biosciences, Inc. |
Tolerogenic synthetic nanocarriers to reduce cytotoxic t lymphocyte responses
|
WO2012177595A1
(en)
|
2011-06-21 |
2012-12-27 |
Oncofactor Corporation |
Compositions and methods for the therapy and diagnosis of cancer
|
CN103702687A
(zh)
|
2011-07-29 |
2014-04-02 |
西莱克塔生物科技公司 |
产生体液和细胞毒性t淋巴细胞(ctl)免疫应答的合成纳米载体
|
WO2013054200A2
(en)
|
2011-10-10 |
2013-04-18 |
The Hospital For Sick Children |
Methods and compositions for screening and treating developmental disorders
|
DK2773779T3
(da)
|
2011-11-04 |
2020-11-23 |
Population Bio Inc |
Fremgangsmåder og sammensætninger til diagnosticering, prognose og forebyggelse af neurologiske tilstande
|
ES2687954T3
(es)
|
2011-11-11 |
2018-10-30 |
Fred Hutchinson Cancer Research Center |
Inmunoterapia de linfocitos T dirigidos a ciclina A1 contra el cáncer
|
DK2812452T3
(da)
|
2012-02-09 |
2020-06-29 |
Population Bio Inc |
Fremgangsmåder og sammensætninger til screening og behandling af udviklingsforstyrrelser
|
CN108771687A
(zh)
|
2012-02-29 |
2018-11-09 |
伊西康内外科公司 |
微生物区系的组合物及与其相关的方法
|
WO2014043519A1
(en)
|
2012-09-14 |
2014-03-20 |
Population Diagnostics Inc. |
Methods and compositions for diagnosing, prognosing, and treating neurological conditions
|
EP2900835A4
(en)
|
2012-09-27 |
2016-05-11 |
Population Diagnotics Inc |
METHODS AND COMPOSITIONS FOR DETECTING AND TREATING DEVELOPMENTAL DISORDERS
|
US10633714B2
(en)
|
2013-07-21 |
2020-04-28 |
Pendulum Therapeutics, Inc. |
Methods and systems for microbiome characterization, monitoring and treatment
|
CN106061963B
(zh)
|
2013-12-20 |
2019-10-22 |
3-V生物科学股份有限公司 |
脂质合成的杂环调节剂和其组合
|
MX2016008841A
(es)
|
2014-01-07 |
2016-10-13 |
3-V Biosciences Inc |
Moduladores heterociclicos de la sintesis de lipidos para su uso contra el cancer e infecciones virales.
|
EA033248B1
(ru)
|
2014-02-20 |
2019-09-30 |
Вэксарт, Инк. |
Композиция и способ индукции иммунного ответа
|
WO2015149016A2
(en)
|
2014-03-28 |
2015-10-01 |
University Of Washington Through Its Center For Commercialization |
Breast and ovarian cancer vaccines
|
EP3169699A4
(en)
|
2014-07-18 |
2018-06-20 |
The University of Washington |
Cancer vaccine compositions and methods of use thereof
|
CA2996445A1
(en)
|
2014-09-05 |
2016-03-10 |
Eli Hatchwell |
Methods and compositions for inhibiting and treating neurological conditions
|
WO2016054240A1
(en)
|
2014-09-30 |
2016-04-07 |
Sean Dalziel |
Fixed dose combinations for the treatment of viral diseases
|
CA2964480A1
(en)
|
2014-10-31 |
2016-05-06 |
Whole Biome Inc. |
Methods and compositions relating to microbial treatment and diagnosis of disorders
|
JP6758314B2
(ja)
|
2015-03-19 |
2020-09-23 |
サギメット バイオサイエンシーズ インコーポレイテッド |
脂質合成の複素環式調節因子
|
CN108024955A
(zh)
|
2015-06-12 |
2018-05-11 |
瓦克萨特公司 |
用于rsv和诺如病毒抗原的小肠递送的制剂
|
AU2017259821B2
(en)
|
2016-05-04 |
2024-07-18 |
Abilita Bio, Inc. |
Methods and platform for preparing multispanning membrane proteins
|
US10294454B2
(en)
|
2016-08-24 |
2019-05-21 |
General Electric Company |
Methods and kits for cell activation
|
US11725232B2
(en)
|
2016-10-31 |
2023-08-15 |
The Hong Kong University Of Science And Technology |
Compositions, methods and kits for detection of genetic variants for alzheimer's disease
|
US10240205B2
(en)
|
2017-02-03 |
2019-03-26 |
Population Bio, Inc. |
Methods for assessing risk of developing a viral disease using a genetic test
|
GB201710973D0
(en)
|
2017-07-07 |
2017-08-23 |
Avacta Life Sciences Ltd |
Scaffold proteins
|
CN111372596A
(zh)
|
2017-08-30 |
2020-07-03 |
潘德勒姆治疗公司 |
用于治疗微生物组相关病症的方法和组合物
|
KR20240014102A
(ko)
|
2018-06-29 |
2024-01-31 |
우한 뉴로프스 바이오테크놀로지 리미티드 컴퍼니 |
레버 유전성 시신경병증의 치료를 위한 조성물 및 방법
|
WO2020001657A1
(en)
|
2018-06-29 |
2020-01-02 |
Wuhan Neurophth Biological Technology Limited Company |
Compositions and methods for treating leber's hereditary optic neuropathy
|
DK3625368T3
(da)
|
2018-08-08 |
2022-12-19 |
Pml Screening Llc |
Fremgangsmåder til vurdering af risiko for udvikling af progressiv, multifokal leukoencephalopati forårsaget af john cunningham-virus ved genetisk test
|
CA3109432A1
(en)
|
2018-08-20 |
2020-02-27 |
Wuhan Neurophth Biotechnology Limited Company |
Compositions and methods for treating leber's hereditary optic neuropathy
|
CN111315407B
(zh)
|
2018-09-11 |
2023-05-02 |
上海市公共卫生临床中心 |
一种广谱抗流感疫苗免疫原及其应用
|
WO2021030251A1
(en)
|
2019-08-12 |
2021-02-18 |
Purinomia Biotech, Inc. |
Methods and compositions for promoting and potentiating t-cell mediated immune responses through adcc targeting of cd39 expressing cells
|
TW202128775A
(zh)
|
2019-10-16 |
2021-08-01 |
英商阿法克塔生命科學有限公司 |
PD-L1抑制劑-TGFβ抑制劑雙特異性藥物部分
|
CN113025633A
(zh)
|
2019-12-09 |
2021-06-25 |
武汉纽福斯生物科技有限公司 |
编码人nadh脱氢酶亚单位1蛋白的核酸及其应用
|
GB202101299D0
(en)
|
2020-06-09 |
2021-03-17 |
Avacta Life Sciences Ltd |
Diagnostic polypetides and methods
|
WO2022234003A1
(en)
|
2021-05-07 |
2022-11-10 |
Avacta Life Sciences Limited |
Cd33 binding polypeptides with stefin a protein
|
WO2023280157A1
(zh)
|
2021-07-05 |
2023-01-12 |
武汉纽福斯生物科技有限公司 |
一种抗vegf抗体体内表达***的构建和应用
|
WO2023011632A1
(zh)
|
2021-08-06 |
2023-02-09 |
武汉纽福斯生物科技有限公司 |
用于治疗由于nd4突变造成的莱伯氏遗传性视神经病变的组合物和方法
|
WO2023057946A1
(en)
|
2021-10-07 |
2023-04-13 |
Avacta Life Sciences Limited |
Serum half-life extended pd-l1 binding polypeptides
|
TW202334196A
(zh)
|
2021-10-07 |
2023-09-01 |
英商阿法克塔生命科學有限公司 |
Pd-l1結合多肽
|
WO2023218243A1
(en)
|
2022-05-12 |
2023-11-16 |
Avacta Life Sciences Limited |
Lag-3/pd-l1 binding fusion proteins
|